JPH09157151A - Melanin generation inhibitor and whitening agent - Google Patents

Melanin generation inhibitor and whitening agent

Info

Publication number
JPH09157151A
JPH09157151A JP7344836A JP34483695A JPH09157151A JP H09157151 A JPH09157151 A JP H09157151A JP 7344836 A JP7344836 A JP 7344836A JP 34483695 A JP34483695 A JP 34483695A JP H09157151 A JPH09157151 A JP H09157151A
Authority
JP
Japan
Prior art keywords
whitening
hypericum
whitening agent
melanin generation
generation inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7344836A
Other languages
Japanese (ja)
Inventor
Megumi Obayashi
恵 大林
Yuri Okano
由利 岡野
Hitoshi Masaki
仁 正木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP7344836A priority Critical patent/JPH09157151A/en
Publication of JPH09157151A publication Critical patent/JPH09157151A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a melanin generation inhibitor having excellent melanin generation inhibiting effect and high safety and stability, containing a specific plant extracted substance. SOLUTION: This melanin generation inhibitor is obtained by mixing one kind or more than two kinds of extracts of Hypericum erectum and Hypericum ascyron as perennial plants in the family Clusiaceae. The extraction is performed to preferably whole herb of the plant in a usual method by using a hydrophilic solvent (e.g. ethanol). A whitening agent is prepared by mixing 0.001-20wt.% of the melanin generation inhibitor. The whitening agent has excellent whitening action, safety and stability, and can be made to a skin preparation for external use for whitening agent and a skin cosmetic for whitening in a shape of lotion, milky agent, cream and ointment, etc.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、特定の植物抽出物
を配合してなる、効果に優れ、且つ安全性及び安定性の
高いメラニン生成抑制剤、及びこれを配合して成る美白
剤に関する。
TECHNICAL FIELD The present invention relates to a melanin production inhibitor having a high effect, high safety and stability, which comprises a specific plant extract, and a whitening agent comprising the same.

【0002】[0002]

【従来の技術】従来より、皮膚の色黒,シミ,ソバカス
等を改善する上で、美白化粧料は非常に関心の深いもの
であり、これらにおいては、アスコルビン酸,グルタチ
オン,コロイドイオウ等が有効成分として配合されてき
た。
2. Description of the Related Art Conventionally, whitening cosmetics have been of great interest in improving skin darkness, dark spots, freckles, and the like. In these, ascorbic acid, glutathione, colloidal sulfur and the like are effective. It has been formulated as an ingredient.

【0003】また、種々の薬用植物抽出物や、植物由来
の没食子酸,ゲラニイン等を用いた例もある。さらに、
コウジ酸やグルコピラノシド誘導体であるアルブチンと
いった美白成分も最近使用されている。かかる美白成分
は、メラニン産生を触媒するチロシナーゼの活性を阻害
するチロシナーゼ活性阻害剤、チロシンからドーパ,ド
ーパキノン,ドーパクロムを経てメラニンを生成する過
程の一部又は全部を切断するメラニン生合成阻害剤、メ
ラニンの代謝を正常化するメラニン排泄促進剤などが知
られている。
There are also examples in which various medicinal plant extracts, plant-derived gallic acid, geraniin and the like are used. further,
Whitening ingredients such as kojic acid and arbutin, a glucopyranoside derivative, have also been used recently. Such a whitening component is a tyrosinase activity inhibitor that inhibits the activity of tyrosinase that catalyzes melanin production, a melanin biosynthesis inhibitor that cleaves part or all of the process of producing melanin from tyrosine via dopa, dopaquinone, and dopachrome, melanin. Known are melanin excretion enhancers that normalize the metabolism of melanin.

【0004】[0004]

【発明が解決しようとする課題】しかしながら、アスコ
ルビン酸は酸化されやすく不安定であり、グルタチオン
やコロイドイオウは特有の異臭や沈殿を生じるという欠
点を有する。
However, ascorbic acid is liable to be oxidized and unstable, and glutathione and colloidal sulfur have drawbacks of producing a peculiar odor and precipitation.

【0005】また、従来の薬用植物抽出物は効果が今一
つ不十分であったり、品質が一定しないといった問題点
があった。さらに、コウジ酸等においてもその安定性の
維持等に配慮しなければならなかった。その他にも、連
用により副作用の生じるものもあった。
In addition, the conventional medicinal plant extracts have problems that the effect is insufficient and the quality is not constant. Furthermore, maintenance of the stability of kojic acid and the like had to be considered. In addition, there were some that caused side effects due to continuous use.

【0006】本発明は、かかる課題を解決し、美白効果
に優れ、かつ安全性及び安定性の高い美白剤を提供せん
とするものである。
The present invention is intended to solve such problems and provide a whitening agent which is excellent in whitening effect and which is highly safe and stable.

【0007】[0007]

【発明を解決するための手段】美白剤,特に美白化粧料
は毎日連用されるものであるため、これに配合する有効
成分としては、作用が穏和で連用により十分な効果を現
わし、しかも連用による副作用のないものが望まれる。
かかる観点からは、天然物由来物質、特に薬用植物の抽
出物が好ましいものであるが、上記した作用の有効性,
品質の安定性等における問題点を解決するため、われわ
れは、植物抽出物の中から、有効且つ穏和な皮膚美白作
用を有し、さらに安定性も高いものをスクリーニングし
た。
Since a whitening agent, especially a whitening cosmetic, is continuously used every day, the active ingredient to be added thereto has a mild action and shows sufficient effects by continuous use, Those without side effects due to are desired.
From this point of view, a substance derived from a natural product, particularly an extract of a medicinal plant is preferable, but the effectiveness of the above-mentioned action,
In order to solve problems such as stability of quality, we screened among plant extracts for effective and mild skin lightening effect and high stability.

【0008】その結果、オトギリソウ(Hypericum erect
um Thunb.又はHypericum perforatum L.),トモエソウ
(Hypericum ascyron L.)の抽出物において、高いメラニ
ン生成抑制作用を見出した。これらの抽出物において
は、皮膚刺激性,接触感作性といった皮膚への悪影響も
なく、また化粧料に配合したときも、メラニン生成抑制
作用の不活化は起こらずに、品質も安定していた。
As a result, Hypericum erect
um Thunb. or Hypericum perforatum L.), Tomoeso
In the extract of ( Hypericum ascyron L.), a high melanin production inhibitory action was found. These extracts had no adverse effects on the skin such as skin irritation and contact sensitization, and when incorporated into cosmetics, the melanin production inhibitory effect was not inactivated and the quality was stable. .

【0009】オトギリソウ(Hypericum erectum Thunb.
又はHypericum perforatum L.)及びトモエソウ(Hyperic
um ascyron L.)は共にオトギリソウ科(Guttiferae)の多
年草である。オトギリソウ(Hypericum erectum Thunb.)
(以下オトギリソウEと略す)は、日本や朝鮮などに分
布しこの全草を乾燥したものはショウレンギョウと呼ば
れる生薬であり、有効成分としてタンニンを含有し、収
れん,含そう,止血剤として使用されている。また、オ
トギリソウ(Hypericum perforatum L.)(以下オトギリ
ソウPと略す)は、主にヨーロッパに分布しており、タ
ンニン,Hypericinを有効成分とする止瀉薬として使用
されている。(廣川薬用植物大事典,廣川書店,1974年)
Hypericum erectum Thunb.
Or Hypericum perforatum L.) and Tomoesou ( Hypericum perforatum L.)
um ascyron L.) is a perennial plant of the family Hypericum ( Guttiferae ). Hypericum ( Hypericum erectum Thunb.)
(Hereinafter, it is abbreviated as Hypericum E) is a herbal medicine that is distributed in Japan, Korea, etc., and this whole plant is dried, and it is a herbal medicine called syringa L. ing. Hypericum perforatum L. (hereinafter referred to as Hypericum P) is mainly distributed in Europe and is used as an antidiarrheal containing tannin and Hypericin as active ingredients. (Encyclopedia of medicinal plants Hirokawa, Hirokawa Shoten, 1974)

【0010】これらオトギリソウE,オトギリソウP,
トモエソウの抽出物を得る際の抽出溶媒としては、通常
の美白剤、化粧料に配合する植物抽出物に適用される抽
出溶媒であれば特に限定されないが、親水性溶媒、特に
含水低級アルコールが好ましく用いられる。低級アルコ
ールとしてはメタノール、エタノール、プロパノール、
イソプロパノール等が例示されるが、エタノールが特に
好ましく用いられる。他に水抽出物や、アセトン,ヘキ
サン等の有機溶媒抽出物を用いても良い。また、抽出部
位は全草、花部、根部等特に限定されないが、全草抽出
物が特に好ましく用いられる。また抽出する際には、乾
燥或いは生植物のどちらを用いても良い。
These Hypericum perforatum E, Hypericum perforatum P,
The extraction solvent when obtaining the extract of Tomoesou is not particularly limited as long as it is an extraction solvent applied to a plant extract to be blended in a normal whitening agent and cosmetics, but a hydrophilic solvent, particularly a hydrous lower alcohol is preferable. Used. Lower alcohols include methanol, ethanol, propanol,
Examples of isopropanol include ethanol, with ethanol being particularly preferred. Alternatively, a water extract or an organic solvent extract such as acetone or hexane may be used. Further, the extraction site is not particularly limited, such as whole grass, flowers, roots, etc., but whole grass extract is particularly preferably used. When extracting, either dried or fresh plants may be used.

【0011】[0011]

【発明の実施の形態】本発明において、上記植物抽出物
より成るメラニン生成抑制剤の美白剤への配合量は、
0.001〜20重量%が適当である。配合量が0.0
01重量%以下であると、十分な美白効果が得られない
が、美白作用がかなり強いため、あまり多量に配合する
必要もなく、20重量%を超えると美白剤の安定性等に
影響を及ぼすこともある。
BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, the compounding amount of the melanin production inhibitor comprising the above plant extract in the whitening agent is
0.001 to 20% by weight is suitable. Compounding amount 0.0
If the amount is less than 01% by weight, a sufficient whitening effect cannot be obtained, but since the whitening effect is quite strong, it is not necessary to add a large amount, and if it exceeds 20% by weight, the stability of the whitening agent will be affected. Sometimes.

【0012】本発明においては、上記のメラニン生成抑
制剤を配合して美白剤を提供しうるが、美白剤として
は、ローション,乳剤,クリーム,軟膏等の形態をとる
ことができる。またさらに、柔軟性化粧水,収れん性化
粧水,洗浄用化粧水等の化粧水類、エモリエントクリー
ム,モイスチュアクリーム,マッサージクリーム,クレ
ンジングクリーム,メイクアップクリーム等のクリーム
類、エモリエント乳液,モイスチュア乳液,ナリシング
乳液,クレンジング乳液等の乳液類、ゼリー状パック,
ピールオフパック,洗い流しパック、粉末パック等のパ
ック類、美容液、及び洗顔料といった、種々の製剤形態
の美白化粧料としても提供することができる。
In the present invention, a whitening agent can be provided by blending the above-mentioned melanin production inhibitor, but the whitening agent can be in the form of a lotion, emulsion, cream, ointment or the like. Furthermore, softening lotion, astringent lotion, lotion such as washing lotion, emollient cream, moisturizing cream, massage cream, cleansing cream, cream such as makeup cream, emollient emulsion, moisturizing emulsion, nourishing Emulsions, cleansing emulsions and other emulsions, jelly packs,
It can also be provided as whitening cosmetics in various formulations, such as packs such as peel-off packs, wash-off packs, powder packs, serums, and face wash.

【0013】本発明においてはさらに、保湿剤,抗炎症
剤,紫外線吸収剤等の他の有効成分を併用することもで
き、日焼け止め化粧料、皮膚保護用化粧料、荒れ肌改善
用化粧料等の薬用化粧料或いは医薬部外品等として提供
することもできる。
In the present invention, other active ingredients such as moisturizers, anti-inflammatory agents, and ultraviolet absorbers can also be used in combination, such as sunscreen cosmetics, skin protecting cosmetics, and rough skin improving cosmetics. It can also be provided as a cosmeceutical or a quasi drug.

【0014】[0014]

【作用】本発明におけるメラニン生成抑制の作用につい
て評価を行った。評価は次のようにして行った。
[Function] The effect of suppressing melanin production in the present invention was evaluated. The evaluation was performed as follows.

【0015】まず、乾燥した植物片10gを50重量%
エタノール100ml中に入れ、室温で1週間抽出を行っ
た。この植物抽出物をろ過後、50重量%エタノールで
100倍希釈して試料溶液を調製した。この試料溶液を
終濃度2〜50μg/mlになるようにマウス由来のメラノ
ーマ細胞系に添加して3日間培養した。培養は細胞数5
000程度から行った。細胞を分離し、650nm及び4
00nmの吸光度を測定しA6及びA4とし、さらに細胞数
nをカウントした。対照として、植物抽出物を配合して
いない系で培養を行い、細胞の650nm及び400nm吸
光度A'6及びA'4、及び細胞数n'の測定を行った。メ
ラニン生成抑制率は、次式(1)により求めた。
First, 10 g of dried plant pieces was added to 50% by weight.
It was put in 100 ml of ethanol and extracted at room temperature for 1 week. This plant extract was filtered and then diluted 100-fold with 50% by weight ethanol to prepare a sample solution. This sample solution was added to a mouse-derived melanoma cell line to a final concentration of 2 to 50 μg / ml and cultured for 3 days. Culture has 5 cells
It started from about 000. Separate the cells, 650 nm and 4
The absorbance at 00 nm was measured and designated as A6 and A4, and the number of cells n was counted. As a control, the cells were cultured in a system containing no plant extract, and the absorbances A′6 and A′4 of the cells at 650 nm and 400 nm and the cell number n ′ were measured. The melanin production suppression rate was calculated by the following equation (1).

【数1】 (Equation 1)

【0016】メラニン生成抑制率の測定結果を表1に示
した。表1より明らかなように、本発明で使用する植物
抽出物は、いずれも有意に高いメラニン生成抑制率を示
し、有効な美白効果を発揮するものである。
Table 1 shows the measurement results of the melanin production inhibitory rate. As is clear from Table 1, each of the plant extracts used in the present invention has a significantly high melanin production inhibitory rate and exhibits an effective whitening effect.

【表1】 [Table 1]

【0017】[0017]

【実施例】さらに本発明の特徴について、実施例により
詳細に説明する。
EXAMPLES Further, the features of the present invention will be described in detail with reference to examples.

【0018】 [実施例1]液状皮膚外用剤 (1)グリセリン 5.0(重量%) (2)プロピレングリコール 4.0 (3)エタノール 10.0 (4)オトギリソウP・50%エタノール抽出物 0.5 (5)パラオキシ安息香酸メチル 0.1 (6)精製水 80.4 (5)を(3)に溶解して(6)に加え、(1),(2),(4)を順次添加
し、混合,均一化する。
[Example 1] Liquid external preparation for skin (1) Glycerin 5.0 (% by weight) (2) Propylene glycol 4.0 (3) Ethanol 10.0 (4) Hypericum P. 50% ethanol extract 0 5 (5) Methyl paraoxybenzoate 0.1 (6) Purified water 80.4 Dissolve (5) in (3) and add to (6), then add (1), (2) and (4) in order. Add, mix and homogenize.

【0019】 [実施例2]化粧水 (1)1,3-ブチレングリコール 3.0(重量%) (2)ソルビトール 2.0 (3)エタノール 10.0 (4)カルボキシビニルポリマー1重量%水溶液 10.0 (5)オトギリソウE・50%エタノール抽出物 0.5 (6)パラオキシ安息香酸メチル 0.1 (7)香料 0.1 (8)精製水 74.3 (6),(7)を(3)に溶解して(8)に加え、(1),(2),(5)を順次
添加して混合した後、(4)を加え、混合,均一化する。
[Example 2] Lotion (1) 1,3-butylene glycol 3.0 (wt%) (2) sorbitol 2.0 (3) ethanol 10.0 (4) carboxyvinyl polymer 1 wt% aqueous solution 10.0 (5) Hypericum perforatum E. 50% ethanol extract 0.5 (6) Methyl paraoxybenzoate 0.1 (7) Perfume 0.1 (8) Purified water 74.3 (6), (7) After dissolving in (3) and adding to (8), (1), (2) and (5) are sequentially added and mixed, then (4) is added, mixed and homogenized.

【0020】 [実施例3]O/W型乳剤性軟膏 (1)白色ワセリン 25.0(重量%) (2)ステアリルアルコール 15.0 (3)ラウリル硫酸ナトリウム 1.0 (4)パラオキシ安息香酸ブチル 0.1 (5)トモエソウ・98%エタノール抽出物 0.5 (6)精製水 58.4 (1)〜(4)の油相成分を混合し75℃に加熱して溶解,均
一化する。75℃に加熱した(6)に油相成分を添加して
乳化し、冷却後40℃にて(5)を順次添加,混合,均一
化する。
Example 3 O / W Emulsion Ointment (1) White Vaseline 25.0 (wt%) (2) Stearyl Alcohol 15.0 (3) Sodium Lauryl Sulfate 1.0 (4) Paraoxybenzoic Acid Butyl 0.1 (5) Tomoesou / 98% ethanol extract 0.5 (6) Purified water 58.4 Mix the oil phase components of (1) to (4) and heat to 75 ° C to dissolve and homogenize . The oil phase component is added to (6) heated to 75 ° C to emulsify, and after cooling, (5) is sequentially added, mixed and homogenized at 40 ° C.

【0021】 [実施例4]O/W乳化型美容液 (1)スクワラン 5.0(重量%) (2)白色ワセリン 2.0 (3)ミツロウ 0.5 (4)ソルビタンセスキオレエート 0.8 (5)ポリオキシエチレンオレイルエーテル(20EO) 1.2 (6)パラオキシ安息香酸メチル 0.1 (7)プロピレングリコール 5.0 (8)精製水 59.6 (9)カルボキシビニルポリマー1.0重量%水溶液 20.0 (10)水酸化カリウム 0.1 (11)エタノール 5.0 (12)オトギリソウE・70%エタノール抽出物 0.5 (13)香料 0.2 (1)〜(6)の油相成分を混合し75℃に加熱して溶解,均
一化する。一方(7),(8)の水相成分を混合,溶解して7
5℃に加熱し、前記の油相成分を添加して予備乳化す
る。(9)を添加した後ホモミキサーにて均一に乳化し、
(10)を加えてpHを調整する。冷却後40℃にて(11)〜
(13)を添加,混合,均一化する。
[Example 4] O / W emulsion type beauty essence (1) Squalane 5.0 (% by weight) (2) White petrolatum 2.0 (3) Beeswax 0.5 (4) Sorbitan sesquioleate 0. 8 (5) Polyoxyethylene oleyl ether (20EO) 1.2 (6) Methyl paraoxybenzoate 0.1 (7) Propylene glycol 5.0 (8) Purified water 59.6 (9) Carboxyvinyl polymer 1.0% by weight Aqueous solution 20.0 (10) Potassium hydroxide 0.1 (11) Ethanol 5.0 (12) Hypericum perforatum E. 70% ethanol extract 0.5 (13) Perfume 0.2 Oils of (1) to (6) The phase components are mixed and heated to 75 ° C. to dissolve and homogenize. On the other hand, the water phase components of (7) and (8) are mixed and dissolved to form 7
The mixture is heated to 5 ° C., the above oil phase component is added, and pre-emulsified. After adding (9), emulsify uniformly with a homomixer,
(10) is added to adjust the pH. After cooling at 40 ℃ (11) ~
Add (13), mix, and homogenize.

【0022】 [実施例5]W/O乳化型クリーム (1)ミツロウ 3.0(重量%) (2)吸着精製ラノリン 10.0 (3)スクワラン 30.0 (4)固形パラフィン 2.0 (5)マイクロクリスタリンワックス 5.0 (6)アジピン酸ヘキシルデシル 10.0 (7)セスキオレイン酸ソルビタン 3.5 (8)ポリオキシエチレン硬化ヒマシ油(50EO) 1.0 (9)1,3-ブチレングリコール 5.0 (10)精製水 29.8 (11)パラオキシ安息香酸メチル 0.2 (12)オトギリソウP・水抽出物 0.5 (1)〜(8)の油相成分を混合し75℃に加熱して溶解,均
一化する。一方(9)〜(11)の水相成分を混合,溶解して
75℃に加熱し、前記の油相成分に添加してホモミキサ
ーにて均一に乳化する。冷却後40℃にて(12)を添加,
混合する。
[Example 5] W / O emulsion type cream (1) Beeswax 3.0 (wt%) (2) Adsorption-purified lanolin 10.0 (3) Squalane 30.0 (4) Solid paraffin 2.0 ( 5) Microcrystalline wax 5.0 (6) Hexyldecyl adipate 10.0 (7) Sorbitan sesquioleate 3.5 (8) Polyoxyethylene hydrogenated castor oil (50EO) 1.0 (9) 1,3- Butylene glycol 5.0 (10) Purified water 29.8 (11) Methyl paraoxybenzoate 0.2 (12) Hypericum perforatum P. water extract 0.5 Mix the oil phase components of (1) to (8) 75 Heat to ℃ to dissolve and homogenize. On the other hand, the aqueous phase components (9) to (11) are mixed and dissolved, heated to 75 ° C., added to the above oil phase components, and uniformly emulsified by a homomixer. After cooling, add (12) at 40 ℃,
Mix.

【0023】上記実施例を用いて、使用試験を行った。
その際、植物抽出物を配合しないものをそれぞれの比較
例とした。パネラーは、皮膚のシミ,ソバカス,日焼け
等の色素沈着を主な症状として有する者20名を一群と
して選出した。各群にそれぞれ実施例及び比較例をブラ
インドにて顔面及び手に使用させ、色素沈着の変化を観
察し、評価した。使用期間は4月から10月の6カ月間
とした。美白効果について、「改善」,「やや改善」,
「変化なし」の3段階にて評価をし、各評価を得たパネ
ラー数にて結果を表2に示した。
A usage test was conducted using the above examples.
At that time, those containing no plant extract were used as comparative examples. The panelists selected 20 persons who had pigmentation such as skin spots, freckles, and sunburn as the main symptoms as a group. Each group was allowed to use the examples and comparative examples on the face and hands with a blind, and changes in pigmentation were observed and evaluated. The period of use was 6 months from April to October. About whitening effect, "improved", "slightly improved",
The evaluation was made in three grades of "no change", and the results are shown in Table 2 by the number of panelists who obtained each evaluation.

【0024】[0024]

【表2】 表2に示した使用試験結果から明らかなように、特定の
種類のオトギリソウ科植物の抽出物を配合した実施例を
使用したパネラーでは、全員色素沈着の改善が認められ
た。これに対し、比較例1〜5を使用したパネラーで
は、はっきりと改善が認められたパネラーはおらず、ほ
とんどのパネラーで変化を認めなかった。以上の結果よ
り、特定の種類のオトギリソウ科植物の抽出物を配合す
ることにより、美白効果を付与することができた。
[Table 2] As is clear from the results of the use test shown in Table 2, all of the panelists using the examples in which the extract of the Hypericumaceae plant of a specific type was blended showed improvement in pigmentation. On the other hand, among the panelists using Comparative Examples 1 to 5, no panelists showed a clear improvement, and almost no panelists showed any change. From the above results, it was possible to impart a whitening effect by blending a specific type of Hypericumaceae plant extract.

【0025】なお、上記の使用期間において、いずれの
実施例を使用した群においても、痛み、痒み等の皮膚刺
激やアレルギー反応等の皮膚症状を訴えたパネラーはい
なかった。また、乳化状態の悪化や配合成分の沈降,変
質等も認められなかった。
No panelists complained of skin symptoms such as skin irritation such as pain and itching, or allergic reaction in any of the groups used in the above-mentioned use period. In addition, no deterioration of the emulsified state, no sedimentation and deterioration of the components were observed.

【発明の効果】【The invention's effect】

【0026】以上詳述したように、オトギリソウ(Hyper
icum erectum Thunb.又はHypericumperforatum L.),ト
モエソウ(Hypericum ascyron L.)の抽出物は、高いメラ
ニン生成抑制作用を有し、さらにこれをメラニン生成抑
制剤として配合した美白用皮膚外用剤及び美白用皮膚化
粧料は、優れた美白作用を示し、さらに安全性、安定性
も良好である。
As described above in detail, Hypericum perforatum ( Hyper
The extract of icum erectum Thunb. or Hypericum perforatum L.) and Tomoesou ( Hypericum ascyron L.) has a high inhibitory effect on melanin production. Further, the external agent for whitening skin and whitening skin containing this as a melanin inhibitor Cosmetics exhibit an excellent whitening effect, and also have good safety and stability.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 オトギリソウ(Hypericum erectum Thun
b.又はHypericum perforatum L.),トモエソウ(Hyperic
um ascyron L.)の抽出物の1種又は2種以上を配合する
ことを特徴とするメラニン生成抑制剤。
1. Hypericum erectum Thun
b. or Hypericum perforatum L.), Tomoesou ( Hypericum perforatum L.)
um ascyron L.) 1 type or 2 types or more of the extract is mix | blended, The melanin production inhibitor characterized by the above-mentioned.
【請求項2】 オトギリソウ(Hypericum erectum Thun
b.又はHypericum perforatum L.),トモエソウ(Hyperic
um ascyron L.)の抽出物の1種又は2種以上をメラニン
生成抑制剤として配合することを特徴とする美白剤。
2. Hypericum erectum Thun
b. or Hypericum perforatum L.), Tomoesou ( Hypericum perforatum L.)
um ascyron L.) one or more kinds of the extract is blended as a melanin production inhibitor.
【請求項3】 美白剤が美白化粧料であることを特徴と
する請求項2に記載の美白剤。
3. The whitening agent according to claim 2, wherein the whitening agent is a whitening cosmetic.
JP7344836A 1995-12-05 1995-12-05 Melanin generation inhibitor and whitening agent Pending JPH09157151A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7344836A JPH09157151A (en) 1995-12-05 1995-12-05 Melanin generation inhibitor and whitening agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7344836A JPH09157151A (en) 1995-12-05 1995-12-05 Melanin generation inhibitor and whitening agent

Publications (1)

Publication Number Publication Date
JPH09157151A true JPH09157151A (en) 1997-06-17

Family

ID=18372355

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7344836A Pending JPH09157151A (en) 1995-12-05 1995-12-05 Melanin generation inhibitor and whitening agent

Country Status (1)

Country Link
JP (1) JPH09157151A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238671B1 (en) * 1998-04-22 2001-05-29 Bionorica Arzneimittel Gmbh Process for the gentle recovery of extract fractions from hypericum, pharmaceutical preparations containing the same and their use
JP2001288052A (en) * 2000-04-10 2001-10-16 Maruzen Pharmaceut Co Ltd Promotor for tyrosinase activity and gray hair- ameliorating agent
JP2003137762A (en) * 2001-11-01 2003-05-14 Noevir Co Ltd Skin care preparation
JP2005015450A (en) * 2003-06-30 2005-01-20 Kanebo Cosmetics Inc Skin cosmetic
JP2016006021A (en) * 2014-06-20 2016-01-14 株式会社ノエビア Thioredoxin-related factor expression promoter
CN117815216A (en) * 2019-04-19 2024-04-05 株式会社资生堂 Anti-photoaging and/or dermis pigmentation inhibitor

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03236322A (en) * 1990-02-13 1991-10-22 Kobayashi Kose Co Ltd Skin drug for external use
JPH0665042A (en) * 1992-08-17 1994-03-08 Kose Corp Skin external preparation
JPH06128145A (en) * 1992-10-16 1994-05-10 Kose Corp External agent for skin
JPH06336421A (en) * 1993-05-28 1994-12-06 Kose Corp External agent for skin
JPH0899858A (en) * 1994-09-30 1996-04-16 Kose Corp Skin external agent
JPH08119825A (en) * 1994-10-20 1996-05-14 Ichimaru Pharcos Co Ltd Hydroxytyrosol, application for skin external medicine or bathing agent
JPH08231343A (en) * 1995-02-24 1996-09-10 Maruzen Pharmaceut Co Ltd Tyrosinase inhibitor, whitening cosmetic and discoloration-preventing agent

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03236322A (en) * 1990-02-13 1991-10-22 Kobayashi Kose Co Ltd Skin drug for external use
JPH0665042A (en) * 1992-08-17 1994-03-08 Kose Corp Skin external preparation
JPH06128145A (en) * 1992-10-16 1994-05-10 Kose Corp External agent for skin
JPH06336421A (en) * 1993-05-28 1994-12-06 Kose Corp External agent for skin
JPH0899858A (en) * 1994-09-30 1996-04-16 Kose Corp Skin external agent
JPH08119825A (en) * 1994-10-20 1996-05-14 Ichimaru Pharcos Co Ltd Hydroxytyrosol, application for skin external medicine or bathing agent
JPH08231343A (en) * 1995-02-24 1996-09-10 Maruzen Pharmaceut Co Ltd Tyrosinase inhibitor, whitening cosmetic and discoloration-preventing agent

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238671B1 (en) * 1998-04-22 2001-05-29 Bionorica Arzneimittel Gmbh Process for the gentle recovery of extract fractions from hypericum, pharmaceutical preparations containing the same and their use
JP2001288052A (en) * 2000-04-10 2001-10-16 Maruzen Pharmaceut Co Ltd Promotor for tyrosinase activity and gray hair- ameliorating agent
JP2003137762A (en) * 2001-11-01 2003-05-14 Noevir Co Ltd Skin care preparation
JP2005015450A (en) * 2003-06-30 2005-01-20 Kanebo Cosmetics Inc Skin cosmetic
JP2016006021A (en) * 2014-06-20 2016-01-14 株式会社ノエビア Thioredoxin-related factor expression promoter
CN117815216A (en) * 2019-04-19 2024-04-05 株式会社资生堂 Anti-photoaging and/or dermis pigmentation inhibitor

Similar Documents

Publication Publication Date Title
JP2000198712A (en) Cosmetic composition
JPH06199647A (en) Skin beautifying cosmetic
JPH0930946A (en) Beautifying and whitening dermal preparation for external use
JPH10330219A (en) Melanogenesis inhibitor and skin whitening agent
JP2002370922A (en) Cosmetic containing japanese plum extract
JPH05139951A (en) Face powder
JP2000169329A (en) Cosmetic composition
JPH11349435A (en) Skin agent used for external use and effective for preventing and improving pigmentary symptom caused by ultraviolet light
JPH09157151A (en) Melanin generation inhibitor and whitening agent
JP3082994B2 (en) Whitening cosmetics
JPH10279428A (en) Cosmetic
JPH1036246A (en) Suppressant for melanogenesis and preparation for external use for skin
JPH10120546A (en) Skin whitening preparation for external use
JP2000256175A (en) Cosmetic composition
JP2011246354A (en) Skin external preparation
JP2000226311A (en) Anti-aging agent
JP6782962B2 (en) TRPM8 activator, cooling sensitizer, cosmetics and oral composition
JP3693243B2 (en) Whitening cosmetics
JP7246125B2 (en) Epidermal cell activator
JPH01149706A (en) Skin-beautifying cosmetic
JP2000159626A (en) Preparation for external use for skin
JP3512143B2 (en) Melanin production inhibitor and whitening agent
JP3026616B2 (en) Whitening cosmetics
JPH04356416A (en) Skin cosmetic
JPH11335230A (en) Skin lotion